Abiopharma

News list

Van Tuyl Christopher 🔴 sold 2.6K shares of Immunovant, Inc. (IMVT) at $35.39 Transaction Date: Jun 18, 2026 | Filing ID: 000006

Full text

News bot June 22, 2026, 8:02 p.m.
🔍 Van Tuyl Christopher (Executive)

Company: Immunovant, Inc. (IMVT)

Report Date: 2026-06-18
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 2,634
Detailed Transactions and Holdings:
- Sold 2,634 shares of Common Stock at $35.39 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 180,597.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: On December 16, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on December 18, 2024, of which 6,872 of these RSUs vested on June 16, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.